Drug Shortage Report for TEVA-VENLAFAXINE XR

Last updated on 2023-04-28 History
Report ID 119904
Drug Identification Number 02275058
Brand name TEVA-VENLAFAXINE XR
Common or Proper name VENLAFAXINE XR 150MG CAP
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) VENLAFAXINE
Strength(s) 150MG
Dosage form(s) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL ORAL
Packaging size 100
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2020-07-08
Estimated end date Unknown
Actual end date 2023-04-27
Shortage status Resolved
Updated date 2023-04-28
Company comments Product is in process of transitioning to the ACT Brand
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2023-04-28 English Compare
v5 2023-04-27 French Compare
v4 2023-04-27 English Compare
v3 2020-07-09 French Compare
v2 2020-07-09 English Compare
v1 2020-07-09 English Compare

Showing 1 to 6 of 6